Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Haemonetics (HAE) Net Cash Flow (2016 - 2025)

Haemonetics (HAE) has 17 years of Net Cash Flow data on record, last reported at $66.1 million in Q4 2025.

  • For Q4 2025, Net Cash Flow rose 138.1% year-over-year to $66.1 million; the TTM value through Dec 2025 reached $35.5 million, down 73.29%, while the annual FY2025 figure was $128.6 million, 225.53% up from the prior year.
  • Net Cash Flow reached $66.1 million in Q4 2025 per HAE's latest filing, up from $4.3 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $167.1 million in Q2 2024 and bottomed at -$160.0 million in Q4 2023.
  • Average Net Cash Flow over 5 years is $9.1 million, with a median of $4.8 million recorded in 2021.
  • Peak YoY movement for Net Cash Flow: crashed 635.35% in 2023, then surged 5077.38% in 2024.
  • A 5-year view of Net Cash Flow shows it stood at $19.6 million in 2021, then tumbled by 210.9% to -$21.8 million in 2022, then plummeted by 635.35% to -$160.0 million in 2023, then soared by 117.35% to $27.8 million in 2024, then surged by 138.1% to $66.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Net Cash Flow were $66.1 million in Q4 2025, $4.3 million in Q3 2025, and -$18.0 million in Q2 2025.